3383-04-8

Basic information

• Product Name: 2,6-DIALLYL PHENYL ALLYL ETHER
• Synonyms: 2,6-DIALLYL PHENYL ALLYL ETHER
• CAS NO: 3383-04-8
• Molecular Formula: C₁₅H₁₈O
• Molecular Weight: 0
• Mol File: 3383-04-8.mol
• Article Data: 1

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 2,6-DIALLYL PHENYL ALLYL ETHER(CAS DataBase Reference)
• NIST Chemistry Reference: 2,6-DIALLYL PHENYL ALLYL ETHER(3383-04-8)
• EPA Substance Registry System: 2,6-DIALLYL PHENYL ALLYL ETHER(3383-04-8)

Safety Data

• Hazardous Substances Data: 3383-04-8(Hazardous Substances Data)

Usage

Description

2,6-DIALLYL PHENYL ALLYL ETHER is a colorless liquid chemical compound belonging to the class of allyl ethers. It is characterized by a strong odor and is insoluble in water but soluble in organic solvents. This versatile chemical is known for its applications in various industries due to its unique properties.

Uses

Used in Polymer Production:
2,6-DIALLYL PHENYL ALLYL ETHER is used as a cross-linking agent in the production of polymers, enhancing their structural integrity and performance characteristics.
Used in Synthesis of Polymeric Materials:
It serves as a monomer in the synthesis of various polymeric materials, contributing to the development of new compounds with specific properties for different applications.
Used in Adhesives Manufacturing:
2,6-DIALLYL PHENYL ALLYL ETHER is used as a component in adhesives, where it increases the hardness and durability of the final product, making it suitable for a wide range of bonding applications.
Used in Coatings Industry:
In the coatings industry, it is utilized to improve the hardness and durability of coatings, providing a longer-lasting and more robust protective layer for various surfaces.
Used in Sealants Production:
2,6-DIALLYL PHENYL ALLYL ETHER is used in the manufacturing of sealants to enhance their performance, ensuring a more effective seal with increased resistance to environmental factors.
Used in Biomedical Applications:
It has been studied for potential use in biomedical applications, such as the development of tissue engineering scaffolds and drug delivery systems, due to its unique properties that may contribute to advancements in medical treatments.
However, it is crucial to handle 2,6-DIALLYL PHENYL ALLYL ETHER with care, as it may cause irritation to the skin, eyes, and respiratory tract upon exposure. Proper safety measures should be taken to minimize any potential health risks associated with its use.

Upstream product

• 3382-99-8 2,6-diallylphenol 
• 106-95-6 allyl bromide 
• 31456-98-1 methyl 3-allyl-salicylate 
• 1745-81-9 o-Allylphenol 
• 100311-33-9 3,5-diallyl-4-hydroxy-benzoic acid 
• 1746-13-0 allyl phenyl ether 
• 71318-55-3 4-hydroxy-3-allyl-benzoic acid 
• 42729-96-4 2-Hydroxy-3-(2-propenyl)-benzoesaeure 
• 59086-52-1 2-allyloxybenzoic acid 
• 3383-05-9 allyl 2-allylphenyl ether 

Downstream Products

• 20490-22-6 2,4,6-tris(2-propenyl)phenol 
• 74663-50-6 2,4,6-tri-n-Propylphenol 

Relevant articles and documents

Sequential Two-Fold Claisen Rearrangement, One-Pot Ring-Closing Metathesis and Cross-Metathesis as a Route to Substituted Benzo[b]azepine-2-one, Benzo[b]azepine and Benzo[b]oxepine Derivatives

A synthetic protocol involving sequential use of three atom-economic processes viz. Claisen rearrangement, ring-closing metathesis and cross metathesis has been developed to access 7-substituted benzo[b]azepine and benzo[b]oxepine derivatives starting from appropriate aniline or phenol in good overall yield. A one-pot RCM-CM protocol has also been developed for the synthesis of benzazepine and benzoxepine derivatives.